Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

John Hamner

Concepts (152)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Recurrence, Local
4
2025
1160
0.800
Why?
Neuroblastoma
8
2009
177
0.770
Why?
Interferon-beta
7
2010
90
0.590
Why?
Gastric Outlet Obstruction
1
2019
12
0.590
Why?
Carcinoma, Signet Ring Cell
1
2019
17
0.580
Why?
Duodenal Neoplasms
1
2019
26
0.580
Why?
Carcinoma, Lobular
1
2019
59
0.560
Why?
Melanoma
5
2025
765
0.520
Why?
Urologic Neoplasms
1
2017
31
0.500
Why?
Skin Neoplasms
5
2025
806
0.500
Why?
Sentinel Lymph Node Biopsy
3
2025
118
0.440
Why?
Hepatectomy
1
2017
256
0.430
Why?
Neoplasms, Second Primary
1
2015
103
0.420
Why?
Pancreaticoduodenectomy
1
2015
149
0.410
Why?
Neovascularization, Pathologic
5
2010
287
0.380
Why?
Carcinoma, Pancreatic Ductal
1
2015
297
0.350
Why?
Breast Neoplasms
2
2019
2418
0.340
Why?
Adenocarcinoma
2
2015
927
0.330
Why?
Liver Neoplasms
1
2017
776
0.320
Why?
Genetic Therapy
3
2008
303
0.290
Why?
Xenograft Model Antitumor Assays
3
2010
930
0.280
Why?
Gene Expression Profiling
2
2025
1792
0.260
Why?
Hydroxamic Acids
1
2008
96
0.260
Why?
Boronic Acids
1
2007
37
0.260
Why?
Pancreatic Neoplasms
1
2015
944
0.250
Why?
Lymphedema
1
2007
23
0.250
Why?
Pyrazines
1
2007
94
0.240
Why?
Mice, SCID
9
2010
360
0.240
Why?
Soft Tissue Neoplasms
1
2007
133
0.230
Why?
Antineoplastic Agents
5
2007
2219
0.210
Why?
Combined Modality Therapy
3
2015
1271
0.190
Why?
Disease-Free Survival
3
2025
778
0.190
Why?
Head and Neck Neoplasms
2
2018
563
0.180
Why?
Aged
10
2025
26432
0.160
Why?
Radiation Tolerance
2
2010
101
0.150
Why?
Stem Cells
3
2009
613
0.150
Why?
Neoplasm Staging
3
2018
1488
0.130
Why?
Cell Line, Tumor
8
2010
3545
0.130
Why?
In Vitro Techniques
3
2009
1041
0.130
Why?
Tumor Burden
4
2018
326
0.130
Why?
Angiogenesis Inhibitors
2
2010
239
0.120
Why?
Prognosis
4
2025
4351
0.120
Why?
Erlotinib Hydrochloride
1
2015
71
0.110
Why?
Follow-Up Studies
3
2017
5439
0.110
Why?
Bone Neoplasms
2
2009
272
0.110
Why?
Adenoviridae
4
2008
197
0.110
Why?
Gastrointestinal Stromal Tumors
1
2015
41
0.110
Why?
Sentinel Lymph Node
2
2025
49
0.100
Why?
Gastrointestinal Neoplasms
1
2015
74
0.100
Why?
Deoxycytidine
1
2015
219
0.100
Why?
Lymph Nodes
1
2017
511
0.100
Why?
Postoperative Complications
1
2007
3034
0.100
Why?
Female
11
2025
79499
0.100
Why?
Thyroid Neoplasms
1
2018
380
0.100
Why?
Humans
21
2025
146342
0.100
Why?
Middle Aged
9
2025
36619
0.100
Why?
Immunotherapy
1
2018
671
0.090
Why?
Stomach Neoplasms
1
2014
128
0.090
Why?
Male
15
2025
73396
0.090
Why?
Health Status Disparities
1
2014
322
0.080
Why?
Healthcare Disparities
1
2018
733
0.080
Why?
Mice
11
2010
18297
0.080
Why?
Lymphatic Metastasis
2
2025
335
0.080
Why?
Rhabdomyosarcoma, Alveolar
1
2010
7
0.080
Why?
Retrospective Studies
5
2018
17438
0.080
Why?
Oxygen Consumption
2
2010
721
0.080
Why?
Osteoprotegerin
1
2009
24
0.070
Why?
Antineoplastic Agents, Alkylating
1
2008
76
0.070
Why?
Transcriptome
2
2025
1068
0.070
Why?
Cyclophosphamide
1
2008
275
0.070
Why?
Subcutaneous Tissue
1
2007
26
0.060
Why?
Bortezomib
1
2007
54
0.060
Why?
Stockings, Compression
1
2007
5
0.060
Why?
Skin Care
1
2007
22
0.060
Why?
Topotecan
1
2007
17
0.060
Why?
Probability
1
2008
309
0.060
Why?
Random Allocation
1
2008
366
0.060
Why?
Neoplasm Transplantation
4
2007
238
0.060
Why?
Neoplasm Metastasis
1
2009
693
0.060
Why?
Animals
11
2010
38107
0.060
Why?
Diphosphonates
1
2006
68
0.060
Why?
Adult
7
2025
41087
0.060
Why?
Drainage
1
2007
187
0.060
Why?
Bone Density Conservation Agents
1
2006
83
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1998
0.060
Why?
Blood Vessels
1
2007
164
0.060
Why?
Glioma
1
2010
425
0.060
Why?
Treatment Outcome
2
2018
11821
0.060
Why?
Clinical Protocols
1
2007
282
0.060
Why?
Blotting, Western
1
2008
1177
0.060
Why?
Imidazoles
1
2006
245
0.050
Why?
Cell Proliferation
2
2010
2502
0.050
Why?
Analgesics
1
2007
230
0.050
Why?
Disease Models, Animal
4
2008
4580
0.050
Why?
Proportional Hazards Models
2
2018
1331
0.050
Why?
Unnecessary Procedures
1
2025
56
0.050
Why?
Pain Measurement
1
2007
573
0.050
Why?
Antibodies, Monoclonal
2
2010
1512
0.050
Why?
Aged, 80 and over
2
2025
8391
0.050
Why?
Sensitivity and Specificity
1
2008
1998
0.050
Why?
Risk Factors
1
2017
10921
0.050
Why?
Antiviral Agents
1
2008
779
0.040
Why?
Prospective Studies
2
2025
8123
0.040
Why?
United States
5
2018
16136
0.040
Why?
Exercise Therapy
1
2007
488
0.040
Why?
Genetic Vectors
3
2008
327
0.040
Why?
Chronic Disease
1
2007
1827
0.040
Why?
Neurons
1
2008
1668
0.040
Why?
Bevacizumab
2
2010
169
0.030
Why?
Biomarkers, Tumor
1
2025
1339
0.030
Why?
Injections, Intravenous
2
2008
197
0.030
Why?
Transduction, Genetic
2
2009
129
0.030
Why?
California
1
2018
475
0.030
Why?
Lymph Node Excision
1
2017
174
0.030
Why?
Kaplan-Meier Estimate
1
2018
970
0.030
Why?
Drug Delivery Systems
2
2008
377
0.030
Why?
SEER Program
1
2014
233
0.020
Why?
Socioeconomic Factors
1
2018
1327
0.020
Why?
Comorbidity
1
2018
1665
0.020
Why?
Antibodies, Monoclonal, Humanized
2
2010
992
0.020
Why?
Databases, Factual
1
2018
1493
0.020
Why?
Sex Factors
1
2018
2107
0.020
Why?
Neoplasms
1
2007
2954
0.020
Why?
Age Factors
1
2018
3347
0.020
Why?
Radiation-Sensitizing Agents
1
2010
43
0.020
Why?
Disease Progression
2
2009
2867
0.020
Why?
Transplantation, Heterologous
1
2010
165
0.020
Why?
Survival Rate
1
2014
2092
0.020
Why?
Radiation, Ionizing
1
2010
84
0.020
Why?
Young Adult
2
2018
14330
0.020
Why?
Cell Hypoxia
1
2010
249
0.020
Why?
Registries
1
2018
2400
0.020
Why?
Incidence
1
2015
2936
0.020
Why?
Statistics, Nonparametric
1
2009
426
0.020
Why?
Angiopoietin-1
1
2007
12
0.020
Why?
Cohort Studies
1
2018
6077
0.020
Why?
Green Fluorescent Proteins
1
2009
408
0.020
Why?
Microcirculation
1
2007
142
0.020
Why?
Dependovirus
1
2007
78
0.020
Why?
Recombinant Proteins
1
2010
1361
0.020
Why?
Cross-Sectional Studies
1
2018
5899
0.010
Why?
Pressure
1
2007
221
0.010
Why?
Vascular Endothelial Growth Factor A
1
2007
545
0.010
Why?
Time Factors
1
2014
7109
0.010
Why?
Cell Movement
1
2007
951
0.010
Why?
Dose-Response Relationship, Drug
1
2006
2022
0.010
Why?
Cell Line
1
2007
2814
0.010
Why?
Cells, Cultured
1
2008
4118
0.010
Why?
Hypoxia
1
2007
1211
0.010
Why?
Cytokines
1
2007
2081
0.010
Why?
Phenotype
1
2007
3206
0.010
Why?
Apoptosis
1
2006
2439
0.010
Why?
Hamner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)